Peptide Companion
Back to catalog
Peptide Companion
single
Other
Vial: 20 mg

Cartalax (20 mg Vial)

Cartalax is a synthetic tripeptide bioregulator (Ala‑Glu‑Asp; sequence “AED”) developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Preclinical studies indicate it may modulate fibroblast proliferation markers (Ki‑67), reduce pro‑apoptotic signaling (p53, caspase‑3), and support extracellular matrix homeostasis. Note: Published human posology for subcutaneous Cartalax is limited; this framework extrapolates from available preclinical and observational data for educational purposes only.

Detailed protocol below.

Dosing Schedule
Week/PhaseDaily Dose (mcg / mg)Units (per injection) (mL)
Weeks 1–22,000 mcg (2.0 mg)30 units (0.30 mL)
Weeks 3–43,000 mcg (3.0 mg)45 units (0.45 mL)
Weeks 5–84,000 mcg (4.0 mg)60 units (0.60 mL)
Weeks 9–125,000 mcg (5.0 mg)75 units (0.75 mL)
Supplies Needed
  • •Peptide Vials (Cartalax, 20 mg each): - 8 weeks ≈ 10 vials - 12 weeks ≈ 15 vials - 16 weeks ≈ 20 vials
  • •Insulin Syringes (U‑100): - Per week: 7 syringes (1/day) - 8 weeks: 56 syringes - 12 weeks: 84 syringes - 16 weeks: 112 syringes
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. - 8 weeks (10 vials): 30 mL → 3 × 10 mL bottles - 12 weeks (15 vials): 45 mL → 5 × 10 mL bottles - 16 weeks (20 vials): 60 mL → 6 × 10 mL bottles
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day. - Per week: 14 swabs (2/day) - 8 weeks: 112 swabs → recommend 2 × 100‑count boxes - 12 weeks: 168 swabs → recommend 2 × 100‑count boxes - 16 weeks: 224 swabs → recommend 3 × 100‑count boxes
References

  • Neuroendocrinology Letters (2002)

    Khavinson VK. Peptides and Ageing. Overview of bioregulatory peptide development and geroprotective mechanisms.

    View source

  • Bulletin of Experimental Biology and Medicine (2016)

    Lin’kova NS et al. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. AED peptide effects on Ki‑67, CD98hc, caspase‑3, and MMP‑9.

    View source

  • Bulletin of Experimental Biology and Medicine (2014)

    Khavinson VK et al. Peptides regulate the expression of signaling molecules in kidney cell cultures during in vitro aging (p53, p16, SIRT‑6).

    View source

  • Molecular Biology Reports (2020)

    Ashapkin V, Khavinson V et al. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.

    View source

  • International Journal of Molecular Sciences (2023)

    Linkova N, Khavinson V et al. Peptide Regulation of Chondrogenic Stem Cell Differentiation.

    View source

  • Advances in Gerontology (2020)

    Khavinson VK, Linkova NS et al. Short peptides: regulation of skin function during aging (collagen, SIRT‑1/‑6, MMP regulation).

    View source

  • PubChem

    Compound summary for Cartalax (AED peptide; CID 87815447): molecular formula C₁₂H₁₉N₃O₈, MW 333.29.

    View source

  • CDC

    Vaccine administration: subcutaneous route (angle/site; no aspiration).

    View source

  • Advances in Therapy (PubMed)

    Subcutaneous injection factors and tolerability; practical volume considerations.

    View source

  • StatPearls (NCBI Bookshelf)

    Medication routes of administration; cautions for large single‑site SC volumes.

    View source

  • Bachem

    Handling and Storage Guidelines for Peptides (lyophilized and reconstituted stability).

    View source

  • NCBI Bookshelf

    Best practices for injection (asepsis, preparation, and administration).

    View source

Educational content adapted from peptidedosages.com. Not medical advice.